WALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — Spyre Therapeutics, Inc. (SYRE) on Thursday reported a loss of $56.3 million in its fourth quarter. The Waltham, Massachusetts-based company said it had a ...

The Waltham, Massachusetts-based company said it had a loss of 81 cents per share. The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment ...

Waltham, Massachusetts-based Revvity ... $138.24 represents a 20.5% premium to RVTY’s current price levels. The Street-high price target of $155 suggests an upside potential of 35.1%.

Repligen expects full-year earnings in the range of $1.67 to $1.76 per share, with revenue in the range of $685 million to $710 million. This story was generated by Automated Insights ( ...

Veralto Corporation (VLTO), headquartered in Waltham, Massachusetts ... Its adjusted EPS of $0.95 surpassed Wall Street expectations of $0.88. The company’s revenue was $1.4 billion, topping ...